Long-Term Safety of Risankizumab in Patients With Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Safety of Risankizumab From 17 Clinical Trials in Patients With Moderate-to-Severe Plaque Psoriasis
Br J Dermatol 2021 Oct 15;[EPub Ahead of Print], KB Gordon, M Lebwohl, KA Papp, H Bachelez, JJ Wu, RG Langley, A Blauvelt, B Kaplan, M Shah, Y Zhao, R Sinvhal, K ReichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.